Aerie Pharmaceuticals, Inc.
(NASDAQ : AERI)

( )
AERI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.04%53.990.9%$1408.53m
JNJJohnson & Johnson 0.02%179.570.7%$1296.66m
BMYBristol-Myers Squibb Co. 0.52%77.991.0%$1218.41m
MRKMerck & Co., Inc. -0.31%92.030.7%$1163.36m
ABBVAbbVie, Inc. 0.34%151.071.9%$1104.03m
LLYEli Lilly & Co. -0.15%313.001.1%$965.80m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%142.980.0%$491.89m
AZNAstraZeneca Plc -0.12%66.621.0%$490.91m
NVSNovartis AG -0.57%90.740.2%$258.37m
GSKGlaxoSmithKline Plc -0.42%44.230.2%$256.49m
VERUVeru, Inc. -0.16%12.620.0%$253.31m
HZNPHorizon Therapeutics Plc 0.00%90.595.4%$196.03m
SGENSeagen Inc. 0.00%138.465.7%$185.67m
NVONovo Nordisk A/S -1.18%105.360.1%$180.73m
VTRSViatris, Inc. -0.42%11.960.0%$164.58m

Company Profile

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NC.